Atlas Trials

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Clinical trial NCT03379844 · COMPLETED

Trial details

NCT number
NCT03379844
Sponsor
UMC Utrecht
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Start date
2017-08-21
Primary completion
2020-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.